127 related articles for article (PubMed ID: 33168093)
1. Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study.
Gebrekidan MG; Gebremedhin GB; Gebregiorgis YS; Gezehegn AA; Weldearegay KT
Antimicrob Resist Infect Control; 2020 Nov; 9(1):184. PubMed ID: 33168093
[TBL] [Abstract][Full Text] [Related]
2. Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia.
Lemma H; Löfgren C; San Sebastian M
Malar J; 2011 Dec; 10():349. PubMed ID: 22141751
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia.
Abamecha A; Yilma D; Addisu W; El-Abid H; Ibenthal A; Noedl H; Yewhalaw D; Moumni M; Abdissa A
Malar J; 2020 Jul; 19(1):240. PubMed ID: 32650784
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
[TBL] [Abstract][Full Text] [Related]
5. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
7. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study.
Nega D; Assefa A; Mohamed H; Solomon H; Woyessa A; Assefa Y; Kebede A; Kassa M
PLoS One; 2016; 11(4):e0154618. PubMed ID: 27128799
[TBL] [Abstract][Full Text] [Related]
9. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
[TBL] [Abstract][Full Text] [Related]
10. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
11. Artemether-Lumefantrine Efficacy for the Treatment of Uncomplicated
Olivera MJ; Guerra AP; Cortes LJ; Horth RZ; Padilla J; Novoa J; Ade MP; Ljolje D; Lucchi NW; Marquiño W; Renteria M; Yurgaky W; Macedo de Oliveira A
Am J Trop Med Hyg; 2020 May; 102(5):1056-1063. PubMed ID: 32100686
[TBL] [Abstract][Full Text] [Related]
12. Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
Obiebi IP
Ghana Med J; 2019 Jun; 53(2):109-116. PubMed ID: 31481806
[TBL] [Abstract][Full Text] [Related]
13. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
14. Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study.
Ebstie YA; Zeynudin A; Belachew T; Desalegn Z; Suleman S
Malar J; 2015 Jun; 14():236. PubMed ID: 26045199
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia.
Mekonnen SK; Medhin G; Berhe N; Clouse RM; Aseffa A
Malar J; 2015 Aug; 14():317. PubMed ID: 26271736
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and Risk Factors Associated with Polymerase Chain Reaction-Determined
Mwaiswelo R; Ngasala B; Jovel I; Xu W; Larsson E; Malmberg M; Gil JP; Premji Z; Mmbando BP; Mårtensson A
Am J Trop Med Hyg; 2019 May; 100(5):1179-1186. PubMed ID: 30860013
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia.
Getnet G; Fola AA; Alemu A; Getie S; Fuehrer HP; Noedl H
Malar J; 2015 Jun; 14():258. PubMed ID: 26105035
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic recrudescence after artemether-lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis.
Mumtaz R; Okell LC; Challenger JD
Malar J; 2020 Dec; 19(1):453. PubMed ID: 33298080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
